2023 annual financial data
Cumberland Pharmaceuticals 2023 Operating cash flow margin
Direct answer
Operating cash flow margin was 15.41%.
Operating income was -9,554,661 USD and net income was -6,279,320 USD.
Operating cash flow was 6,093,821 USD.
Get free Cumberland Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 39,552,507 USD
- Operating income
- -9,554,661 USD
- Net income
- -6,279,320 USD
- Operating cash flow
- 6,093,821 USD